Dr. Taylor on the Current Treatment Landscape for Endometrial Cancer

Video

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

According to Taylor, the mainstay of treatment is chemotherapy. It is important to give systemic treatment, but if a patient presents with disease that can be surgically removed, there is a debate about whether they should have surgery first.

Ideally, a patient can have complete cytoreduction, meaning they undergo surgery and then receive chemotherapy, explains Taylor. The results with surgery when the patient undergoes cytoreduction can be associated with a high risk of complications.

Related Videos
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
Somedeb Ball, MBBS, assistant professor, medicine, Division of Hematology Oncology, Department of Medicine, Vanderbilt University Medical Center
Phillip J. Koo, MD
Gabriella Smith, MD
Mikkael A. Sekeres, MD, MS
Francesco Di Meo, PhD
Ko Un “Clara” Park, MD
Naseema Gangat, MBBS
Erin Frances Cobain, MD
Pashtoon Murtaza Kasi, MD, MS